Introduction: organ involvement in the cardiometabolic syndrome.
about
Ultrastructure of islet microcirculation, pericytes and the islet exocrine interface in the HIP rat model of diabetes.Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndromeCalcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.Improvement of insulin sensitivity by antagonism of the renin-angiotensin system.Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat.Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant alpha-lipoic acid on insulin resistance in the obese Zucker ratNoninvasive diagnosis of subclinical atherosclerosis in cardiometabolic syndrome: a call to action.Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities.Metabolic interactions of AGE inhibitor pyridoxamine and antioxidant alpha-lipoic acid following 22 weeks of treatment in obese Zucker rats.Does the small tyrosine kinase inhibitor Imatinib mesylate counteract diabetes by affecting pancreatic islet amyloidosis and fibrosis?Cardiomyocyte changes in the metabolic syndrome and implications for endogeneous protective strategies.Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus.The high-fat-fed lean Zucker rat: a spontaneous isocaloric model of fat-induced insulin resistance associated with muscle GSK-3 overactivity.
P2860
Q33353268-1C544E2B-B775-4105-A519-8727CCC0E57AQ33840829-615C03D4-D799-4FAE-AE3B-4DBDB7E8372FQ34185823-8793A658-83F5-4EE9-A160-A098DA7B7ED1Q36854401-AF423502-0873-4442-B772-CEE00A37FDF0Q36976385-A48F16A3-2148-4CC1-B4AF-4CADBB1E63ADQ37029246-609A2F6E-2546-41FF-8D6C-AB1FACB06352Q37104545-15A49D10-1B3B-424A-8568-18FAB366EFFAQ37106512-9517B3BA-75A8-4821-BB38-D42645CE1052Q37151490-583768CB-85A8-4465-B38F-DD5796F7F50AQ38045474-9CF7B14C-3C94-4E65-A91A-64D8076E1E34Q38191658-4946E650-8C87-4079-9464-5E8B65C1D4D7Q38354900-88226AB5-7A03-44DE-9D67-536E5520F3C3Q46667055-1B041F0F-F71D-4B0B-AB97-7EA9B73DB003
P2860
Introduction: organ involvement in the cardiometabolic syndrome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Introduction: organ involvement in the cardiometabolic syndrome.
@en
type
label
Introduction: organ involvement in the cardiometabolic syndrome.
@en
prefLabel
Introduction: organ involvement in the cardiometabolic syndrome.
@en
P2093
P2860
P1476
Introduction: organ involvement in the cardiometabolic syndrome.
@en
P2093
Craig S Stump
James R Sowers
Melvin R Hayden
P2860
P356
10.1111/J.0197-3118.2006.05454.X
P577
2006-01-01T00:00:00Z